Celltrion, 296,757 Shares Net Bought by Individuals Over Last 5 Days... Stock Price at 257,500 KRW (+0.39%)
As of 12:31 PM on the 19th, Celltrion is trading at 257,500 KRW, up 0.39% from the previous day. The trading volume is 314,312 shares, which is 59.1% of the previous day's volume. Celltrion is known as a protein and biopharmaceutical manufacturing company.
On October 19, Lee Dong-geon, a researcher at Shinhan Financial Investment, stated, "After a stock rally due to strong first-half performance, the stock price rise has slowed in the second half. However, 1) excluding R&D expenses for COVID-19 treatments, strong performance is expected to continue, 2) sales growth of the highly profitable Remsima SC in 2021 is anticipated, and 3) considering the bio-similar development capabilities and the existing follow-up pipeline, there is sufficient basis for further stock price increases at this point." He set Celltrion's target price at 360,000 KRW.
Over the past five days, individual investors have net purchased 296,757 shares of Celltrion, while foreigners and institutions have net sold 268,408 shares and 40,286 shares, respectively.
Hot Picks Today
Taking Annual Leave and Adding "Strike" to Profiles, "It Feels Like Samsung Has Collapsed"... Unsettled Internal Atmosphere
- There Is a Distinct Age When Physical Abilities Decline Rapidly... From What Age Do Strength and Endurance Drop?
- "One Comment Could Lead to a Report": 86% of Elementary Teachers Feel Anxious; Half Consider Resignation or Career Change
- "After Vowing to Become No. 1 Globally, Sudden Policy Brake Puts Companies’ Massive Investments at Risk"
- On Teacher's Day, a Student's Gifted Cake Had to Be Cut into 32 Pieces... Why?
※Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
